epigenomics
Sitemap Search Glossary Terms Contact Deutsch
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Epigenomics AG Receives Allowance for Key Technology Patent in Japan Thursday, 11.03.2010
Patent broadly covers HeavyMethyl, a core technology of Epigenomics’ molecular diagnostic products

Press release, Berlin, Germany, and Seattle, WA, USA, March 11, 2010
Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG: PRESEPT Academic Research Study Meets Its Primary Objective Monday, 08.03.2010
Epigenomics AG Introduces New Lung Cancer Test at German Cancer Congress Wednesday, 24.02.2010
New IVD test expected to be launched in Q2 2010

Test supports accurate diagnosis of lung cancer in suspicious cases

Conference presentations on scientific evidence and clinical utility

Press release, Berlin, Germany, and Seattle, WA, U.S.A.,
Epigenomics AG: Blood Test for Colorectal Cancer Now Available Nationwide in Germany and Switzerland Tuesday, 23.02.2010
Colorectal cancer test Epi proColon now available nationwide in Germany and Switzerland four months after product launch

Epigenomics to present recent clinical data at 29th German Cancer Congress (Deutscher Krebskongress) in Berlin, Germany

Press release, Berlin, Germany, and Seattle, WA, U.S.A.,
Epigenomics AG Reports Conclusions from PRESEPT Study Audit Thursday, 04.02.2010
  • Differences in analytical instrument read-out requires verification and potential retesting of samples measured in laboratory with deviating results 
  • Top-line data expected still in Q1 2010 
  • No impact on commercial strategy expected

Press release, Berlin, Germany, and Seattle, WA, U.S.A.

Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG Releases Preliminary PRESEPT Study Data Friday, 15.01.2010
Ad Hoc Announcement pursuant of §15 WpHG (German Securities Trading Act): Epigenomics AG: Licensing Partner Quest Diagnostics Introduces Colorectal Cancer Blood Test in the U.S. Monday, 11.01.2010

top of the page